PTEN/P13K pathways are involved in the signal transduction of myocardial remodeling in patients with congestive heart failure

National Medical Journal of China

Volumn 85, Issue 17, 2005, Pages 1201-1204

  Yang, Yong Jian ^a   Zhu, Wen Ling ^a   Zhang, Xin ^a   Zhou, Xing Wen ^a   Zhu, Zhi Ming ^a  

^a PLA General Surgery Center   (China)

Author keywords

1 Phosphatidy linositol 3 kinase; Congestive; Heart failure; Signal transduction; Ventricular remodeling

Indexed keywords

ALPHA ACTIN; BETA ACTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PTEN PROTEIN, HUMAN;

ACCIDENT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION FUNCTION; DEATH; HEART FUNCTION; HEART MUSCLE CELL; HEART PAPILLARY MUSCLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOPRECIPITATION; INTERSTITIUM; MITRAL VALVE DISEASE; MUSCLE TISSUE; ORGAN DONOR; PATHOGENESIS; PATHOLOGY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STATISTICAL ANALYSIS; VALVULAR HEART DISEASE; ADULT; BIOSYNTHESIS; ENZYMOLOGY; FEMALE; GENETICS; HEART MUSCLE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 18844384456     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. 23, is a dual-specificity phosphaase. Proc Natl Acad Sci, 1997, 94: 9052-9057.
2. Maehama T, Dixon J E. PTEN: A tumor suppressor that functions as a phospholipid phosphatase. Trens cell Biol, 1999, 9: 125-128.
3. Chen QY, Wang CY, Wu HS, et al. Exogenous PTEN gene induces apoptosis in breast cancer cells. Natl Med J China, 2005, 85: 33-35.
4. Shi YH, Wang YX, You JF, et al. Activation of HIF-1 by bFGF in breast cancer: role of PI-3 K and MEK/ERK path ways. Natl Med J China, 2004,84:1899-1903.
5. Crackower MA, Oudit GY, Kozieradzki I, et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell, 2002, 110: 737-749.
6. Simpson L, Parsons R. PTEN: Life as a tumor suppressor. Experimental Cell Res, 2001, 264: 29-41.
7. Qudit GY, Sun H, Kerfant BG, et al. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cardiol, 2004, 37: 449-471.
8. Latronico MV, Constinean S, Lavitno MI, et al. Regulation of cell size and contractile function by Akt in cardiomyocytes. Ann N Y Acad Sci, 2004, 1015: 250-260.
9. Schwartzbauer G, Robbins J. The tumor suppressor gene PTEN can regulate cardiac hypertrohy and survival. J Biol Chem, 2001, 276: 35786-35793.
10. Li X, Yang Y, Hu Y, et al. Alphavbeta 6-Fyn signaling promotes oral cancer progression. J Biol Chem, 2003, 278: 41646-41653.
11. Hasenfuss G. Alteration of calcium-regulatory proteins in heart failure. Cardiovasc Res, 1998, 37: 279.
12. Williams RT. Calcium: outside/inside homeostasis and signalling. Biochem Biophys Acta, 1998, 1448: 153-165.
13. Yamazaki T, Komuro I, Shiojima I, et al. The molecular mechanism of cardiac hypertrophy and failure. Ann NY Acad Set, 1999, 874: 39-48.
14. Molkentin JD. Calcineurin and beyond: cardiac hypertrophic signaling. Circ Res, 2000, 87: 731-738.